PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
about
PI3K/AKT/mTOR Pathway in AngiogenesisLoss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathwayThe role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populationsHypoxia-independent drivers of melanoma angiogenesisTargeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayPI3K/PTEN signaling in angiogenesis and tumorigenesisNovel non-AR therapeutic targets in castrate resistant prostate cancerHS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapyInsulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathwayInhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cellsMultimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular responseAntisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cellsDietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathwayStat3 mediates myeloid cell-dependent tumor angiogenesis in miceThe PI3K/Akt signaling pathway exerts effects on the implantation of mouse embryos by regulating the expression of RhoAConcurrent Down-Regulation of PTEN and NKX3.1 Expression in Iranian Patients with Prostate CancerNickel and the microbial toxin, MALP-2, stimulate proangiogenic mediators from human lung fibroblasts via a HIF-1alpha and COX-2-mediated pathwaymiTALOS: analyzing the tissue-specific regulation of signaling pathways by human and mouse microRNAsThe novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancerAntibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate CancerArginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathwayLoss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cellsTriiodothyronine increases mRNA and protein leptin levels in short time in 3T3-L1 adipocytes by PI3K pathway activationα-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutationRedox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndromeInterleukin-32 expression in the pancreasDifferential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2Nuclear PTEN levels and G2 progression in melanoma cellsUnique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cellsThe Role of PTEN in Tumor AngiogenesisCXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activationAkt mediates metastasis-associated gene 1 (MTA1) regulating the expression of E-cadherin and promoting the invasiveness of prostate cancer cellsKLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulationGrowth inhibition of human gastric adenocarcinoma cells in vitro by STO-609 is independent of calcium/calmodulin-dependent protein kinase kinase-beta and adenosine monophosphate-activated protein kinaseActivation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated TumorigenesisHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsA novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cellsPI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cellsSustained proliferation in cancer: Mechanisms and novel therapeutic targets
P2860
Q21129332-1EE29C76-F7D3-4CF4-A6C0-DAC5EEF39572Q24304210-7CE2410A-8756-4FD3-88B7-7080CCE39A61Q24646816-44B1F97B-AB92-4E91-A2C4-7E4FE0F9DEA6Q27022246-369205DD-6CA5-4030-B679-2BAE73CD9646Q28382812-3B1F4F5A-BED5-4B99-B294-1C74C87FBBB5Q28383083-38625104-D170-45FF-91B6-3D1B2915D330Q28383663-E48E9D15-AD62-497D-BCBA-660FEF34BB78Q28383826-5A038F75-032A-4678-B078-D8D97498E68FQ28384176-00874F3C-1A2A-4C56-AE8D-5E4BDB70E269Q28384554-F7FF6E27-5A04-4795-8BB2-07E639AA17E8Q28384680-66FD0E24-3404-470E-8E46-39807397059CQ28384798-55E21C4C-0694-4DAA-BABC-F3BC7205BF9EQ28385231-CD37B109-3662-4223-B506-228B24AB9F4EQ28385532-08B28E3A-3F09-40C4-B6EA-EC3DFFF08028Q28385885-2C232B03-367D-4DB7-AB2E-D1EB36B6A98BQ28387281-C75E596E-BA2A-4143-B70D-6EA9C9EAB5ECQ28387389-2BEC2043-2282-40AD-BAC8-DFDE58670863Q28387968-CD40E0FF-1234-4DF6-BCA5-518A3BD7658AQ28388047-CD50BBBA-A92B-443D-A9A0-615639AACCCBQ28388072-D7A88524-EBC5-493E-9324-062D40A7A7C7Q28388238-07451C30-816D-428E-9574-E99C07EB1DD8Q28388722-1F6ED05E-130B-4D5F-90E9-C0952FC0A746Q28388841-F798DB3A-8779-4C6E-A9BE-1047E2C66A28Q28389681-F5E30E55-9BF7-440E-ABB4-3FD27B425A8AQ28389912-6D52CFE6-F786-4293-A50E-26C4EABC8618Q28390023-F2509419-E190-4C3B-9A81-9A1FC0546E19Q28390987-D436FD9D-07C1-4D6B-829A-182F9BA4918EQ28391204-B13760E7-44B9-44FD-BF56-3099553F6A79Q28391298-4620AA60-981B-4849-9F63-38D6CF815B72Q28391620-8590FD7C-9527-4D79-B14D-F034C33B1012Q28391721-2AB21821-0958-4B40-858B-95D19E16056BQ28391747-530F075C-EB18-46BD-BB3B-B99F1E3EC96CQ28393007-DF4A95C5-634F-46A0-B450-35C913A84825Q28393172-DEB79955-0FC6-4D23-A5EE-CC4A21FCA7DBQ28393661-B5838A1C-37D3-4E0E-B210-75B308401004Q28393897-FFD3825C-4C7C-4536-88FA-F300D336E69AQ28393898-98AF706C-3E46-4A8A-8542-0988E19C279CQ28394160-7985D2D6-8CB3-4EA8-A3FA-28E2A39103DFQ28395725-2233EEA3-D9C0-48CE-8BCC-946FC5B9F521Q28396388-9AC78B9E-C7D7-46C6-89E8-D777E284EA20
P2860
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@ast
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@en
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@en-gb
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@nl
type
label
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@ast
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@en
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@en-gb
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@nl
prefLabel
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@ast
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@en
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@en-gb
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@nl
P2860
P50
P921
P3181
P1433
P1476
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
@en
P2093
P2860
P2880
P304
P3181
P356
10.1016/J.CELLSIG.2007.07.025
P407
P577
2007-12-01T00:00:00Z